MALCOLM JAN (CIK 2028640) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-17). Recent activity: Sell UTHR (45 shares), Sell UTHR (50 shares), Sell UTHR (50 shares), Sell UTHR (50 shares), Sell UTHR (50 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 45 | $24,008 |
| 2026-03-03 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 50 | $25,460 |
| 2026-02-17 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 50 | $23,734 |
| 2026-02-03 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 50 | $23,712 |
| 2026-01-20 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 50 | $23,049 |
| 2026-01-06 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 50 | $24,750 |
| 2025-12-23 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 50 | $25,606 |
| 2025-12-12 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 50 | $24,149 |
| 2025-09-10 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 700 | $280,203 |
| 2025-07-28 | UNITED THERAPEUTICS Corp (UTHR) | Director | Buy | 630 | $0 |
| 2025-07-28 | UNITED THERAPEUTICS Corp (UTHR) | Director | Buy | 590 | $0 |
Source: SEC Form 4 filings · as of 2026-03-17